Assenagon Asset Management’s Zimmer Biomet ZBH Stock Holding History

Assenagon Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.86M	Buy	102,862 +97,887	+1,968%	+$8.58M	0.01%	559
2026 Q1	$450K	Sell	4,975 -248	-5%	-$22.8K	﹤0.01%	1014
2025 Q4	$470K	Sell	5,223 -2,401	-31%	-$228K	﹤0.01%	1051
2025 Q3	$751K	Buy	7,624 +190	+3%	+$18.8K	﹤0.01%	977
2025 Q2	$678K	Sell	7,434 -21,258	-74%	-$2.06M	﹤0.01%	990
2025 Q1	$3.25M	Buy	28,692 +202	+0.7%	+$21.6K	0.01%	638
2024 Q4	$3.01M	Buy	28,490 +345	+1%	+$37K	﹤0.01%	833
2024 Q3	$3.04M	Buy	28,145 +3,859	+16%	+$421K	0.01%	840
2024 Q2	$2.64M	Buy	24,286 +815	+3%	+$96.1K	0.01%	818
2024 Q1	$3.1M	Sell	23,471 -1,010	-4%	-$126K	0.01%	734
2023 Q4	$2.98M	Sell	24,481 -169	-0.7%	-$18.9K	0.01%	785
2023 Q3	$2.77M	Buy	24,650 +2,384	+11%	+$303K	0.01%	742
2023 Q2	$3.24M	Buy	22,266 +13,865	+165%	+$1.88M	0.01%	604
2023 Q1	$1.09M	Buy	8,401 +5,036	+150%	+$632K	﹤0.01%	1022
2022 Q4	$429K	Buy	3,365 +210	+7%	+$24.4K	﹤0.01%	1198
2022 Q3	$330K	Buy	3,155 +2,046	+184%	+$225K	﹤0.01%	1181
2022 Q2	$117K	Sell	1,109 -155	-12%	-$18.4K	﹤0.01%	1405
2022 Q1	$162K	Sell	1,264 -11	-0.9%	-$1.33K	﹤0.01%	1367
2021 Q4	$157K	Sell	1,275 -166	-12%	-$21.7K	﹤0.01%	1385
2021 Q3	$205K	Buy	+1,441	New	+$212K	﹤0.01%	1233
2020 Q3	–	Sell	-11,888	Closed	-$1.55M	–	1388
2020 Q2	$1.38M	Hold	11,888	–	–	0.01%	708
2020 Q1	$1.17M	Sell	11,888 -6,465	-35%	-$847K	0.01%	490
2019 Q4	$2.67M	Buy	18,353 +8,774	+92%	+$1.21M	0.02%	366
2019 Q3	$1.28M	Buy	9,579 +103	+1%	+$13.3K	0.01%	501
2019 Q2	$1.08M	Sell	9,476 -6,798	-42%	-$796K	0.01%	699
2019 Q1	$2.02M	Sell	16,274 -3,399	-17%	-$386K	0.02%	512
2018 Q4	$1.98M	Buy	19,673 +10,963	+126%	+$1.23M	0.02%	451
2018 Q3	$1.11M	Buy	8,710 +2,169	+33%	+$258K	0.01%	625
2018 Q2	$708K	Buy	6,541 +2,136	+48%	+$232K	0.01%	393
2018 Q1	$466K	Buy	4,405 +335	+8%	+$38.9K	0.01%	478
2017 Q4	$477K	Sell	4,070 -16	-0.4%	-$1.81K	﹤0.01%	617
2017 Q3	$464K	Buy	+4,086	New	+$472K	﹤0.01%	419

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Assenagon Asset Management's ZBH Position: Q2 2026 in Review

Assenagon Asset Management increased its Zimmer Biomet (ZBH) stake by 1,968% in Q2 2026, buying an estimated $8.58M and bringing the position to 102,862 shares worth $8.86M. The position accounts for 0.01% of the portfolio, ranked #559.

Assenagon Asset Management first reported a position in ZBH in Q3 2017 and has held it in 32 quarters since. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Assenagon Asset Management held 102,862 shares of Zimmer Biomet worth $8.86M as of Q2 2026.
Assenagon Asset Management bought 97,887 Zimmer Biomet shares in Q2 2026, an estimated $8.58M.
Zimmer Biomet made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #559 holding.
Assenagon Asset Management first reported a position in Zimmer Biomet in Q3 2017 and has held it in 32 quarters since.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.